Clinical Evaluation of White Spot Lesions Treated by S-PRG and ICON

计划入组 20 人 · 首次发布于 2022 年 9 月 22 日

Effect of Bioactive Resin Material Containing S-PRG Filler on White Spot Lesions

计划入组 50 人 · 首次发布于 2026 年 7 月 21 日

Caries Prevention Effect of S-PRG Filler Incorporated in Denture Base Resins on Edentulous Elderly People

计划入组 150 人 · 首次发布于 2015 年 6 月 2 日

PRG-S-2

PRG-S-4

PRG-S-3

T & S HOME OXYGEN SUPPLY COMPANY, INC.

United States

PRG Science & Technology Co., Ltd.

LIVERPOOL SCHOOL OF TROPICAL MEDICINE

United Kingdom

FDA Authorizes Phase 2a Trial of Progerinin for Hutchinson-Gilford Progeria Syndrome

Sentynl Therapeutics Licenses Progerinin for Hutchinson-Gilford Progeria Syndrome Treatment

PRG S&Tech's Trineumin Receives Therapeutic Use Approval in Korea for NF2, the World's First Small Molecule Targeting the Disease Mechanism